Analysts Changed Price Targets on These Stocks Today

Following is information on companies for which stock analysts reiterated their coverage of the stock:

  • YUM! Brands (NYSE:YUM): RBC Capital Mkts reiterated its rating of Outperform for this stock.  It changed its price target from $59 to $65.  About the company: Yum! Brands, Inc, owns and franchises quick-service restaurants worldwide. The Company develops, operates, franchises and licenses a worldwide system of restaurants which prepare, package and sell a menu of food items. Competitors to Watch: McDonald’s Corporation (NYSE:MCD), Wendy’s Arby’s Group Inc. (NYSE:WEN), Carrols Restaurant Group, Inc. (NASDAQ:TAST), Morgan’s Foods, Inc. (MRFD), Papa John’s Int’l, Inc. (NASDAQ:PZZA), Domino’s Pizza, Inc. (NYSE:DPZ), Chipotle Mexican Grill, Inc. (NYSE:CMG), Nathan’s Famous, Inc. (NASDAQ:NATH), Jack in the Box Inc. (NASDAQ:JACK), Starbucks Corporation (NASDAQ:SBUX), Sonic Corporation (NASDAQ:SONC) and AFC Enterprises, Inc. (NASDAQ:AFCE).
  • Valeant Pharmaceuticals (NYSE:VRX): RBC Capital Mkts reiterated its rating of Outperform for this stock.  It changed its price target from $55 to $58.  About the company: Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
  • Petrohawk Energy (NYSE:HK): RBC Capital Mkts reiterated its rating of Outperform for this stock.  It changed its price target from $36 to $39.  About the company: Petrohawk Energy Corporation is an oil and gas company. The Company participates in the exploration and production of natural gas and crude oil. Petrohawk’s operations are currently focused in proven oil and gas producing trends primarily in South Texas, Louisiana, and Central California.
  • Google (NASDAQ:GOOG): RBC Capital Mkts reiterated its rating of Outperform for this stock.  It changed its price target from $680 to $790.  About the company: Google Inc. is a global technology company that provides a web based search engine through its website. The Company offers a wide range of search options, including web, image, groups, directory, and news searches. Competitors to Watch: Microsoft Corporation (NASDAQ:MSFT), Yahoo! Inc. (NASDAQ:YHOO), Baidu.com, Inc. (NASDAQ:BIDU), Apple Inc. (NASDAQ:AAPL), AOL, Inc. (NYSE:AOL), Amazon.com, Inc. (NASDAQ:AMZN), Adobe Systems Incorporated (NASDAQ:ADBE), Demand Media Inc (NYSE:DMD), IAC/InterActiveCorp (NASDAQ:IACI), and Answers Corporation (NASDAQ:ANSW).
  • Triumph Group (NYSE:TGI): Standpoint Research reiterated its rating of Buy for this stock.  It changed its price target from $115 to $58.  About the company:  Triumph Group, Inc. designs, engineers, manufactures, repairs, overhauls, and distributes aircraft components. These components include mechanical and electromechanical control systems, aircraft and engine accessories, auxiliary power units, avionics, and aircraft instruments. The Company serves commercial airlines, air cargo carriers, and various original equipment manufacturers
  • YUM! Brands (NYSE:YUM): Argus reiterated its rating of Buy for this stock.  It changed its price target from $62 to $64.  About the company: Yum! Brands, Inc, owns and franchises quick-service restaurants worldwide. The Company develops, operates, franchises and licenses a worldwide system of restaurants which prepare, package and sell a menu of food items.
  • Triumph Group (NYSE:TGI): Stifel Nicolaus reiterated its rating of Buy for this stock.  It changed its price target from $120 to $60.  About the company: Triumph Group, Inc. designs, engineers, manufactures, repairs, overhauls, and distributes aircraft components. These components include mechanical and electromechanical control systems, aircraft and engine accessories, auxiliary power units, avionics, and aircraft instruments. The Company serves commercial airlines, air cargo carriers, and various original equipment manufacturers.
  • ConocoPhillips (NYSE:COP): Oppenheimer reiterated its rating of Outperform for this stock.  It changed its price target from $82 to $90.  About the company: ConocoPhillips is an international, integrated energy company which operates in several business segments. The Company explores for and produces petroleum, and refines, markets, supplies, and transports petroleum. ConocoPhillips also gathers and processes natural gas, and produces and distributes chemicals and plastics. Competitors to Watch: Chevron Corporation (NYSE:CVX), Exxon Mobil Corporation (NYSE:XOM), BP plc (NYSE:BP), Marathon Oil Corporation (NYSE:MRO), Hess Corp. (NYSE:HES), China Petroleum & Chemical Corp. (NYSE:SNP), TOTAL S.A. (NYSE:TOT), Suncor (NYSE:SU) and Statoil ASA (NYSE:STO).
  • Cubist Pharma (NASDAQ:CBST): Oppenheimer reiterated its rating of Outperform for this stock.  It changed its price target from $37 to $44.  About the company: Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company’s lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections. Competitors to Watch: Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR), Merck & Co., Inc. (NYSE:MRK), Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA), Theravance, Inc. (NASDAQ:THRX), Pfizer Inc. (NYSE:PFE), Novartis AG (NYSE:NVS), The Medicines Company (NASDAQ:MDCO) and Abbott Laboratories (NYSE:ABT).
  • Google (NASDAQ:GOOG): Oppenheimer reiterated its rating of Outperform for this stock.  It changed its price target from $650 to $690.  About the company: Google Inc. is a global technology company that provides a web based search engine through its website. The Company offers a wide range of search options, including web, image, groups, directory, and news searches.
  • Seattle Genetics (NASDAQ:SGEN): Oppenheimer reiterated its rating of Outperform for this stock.  It changed its price target from $21 to $24.  About the company: Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company’s technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer. Competitors to Watch: Pfizer Inc. (NYSE:PFE), Bristol Myers Squibb Co. (NYSE:BMY), Biogen Idec Inc. (NASDAQ:BIIB), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Genzyme Corporation (NASDAQ:GENZ), Micromet Inc. (NASDAQ:MITI), Allos Therapeutics, Inc. (NASDAQ:ALTH), Cephalon, Inc. (NASDAQ:CEPH), Celgene Corporation (NASDAQ:CELG), Merck (NYSE:MRK) and ImmunoGen, Inc. (NASDAQ:IMGN).
  • Tiffany & Co (NYSE:TIF): Oppenheimer reiterated its rating of Outperform for this stock.  It changed its price target from $80 to $100.  About the company: Tiffany & Co. operates jewelry and specialty retail stores and designs and manufactures its products through subsidiary companies. The Company retails its products through stores and boutiques in the United States, Mexico, Canada, and Brazil, and wholesales outside the United States. Tiffany also markets through the Internet and catalogs. Competitors to Watch: Zale Corporation (NYSE:ZLC), Blue Nile, Inc. (NASDAQ:NILE), DGSE Companies, Inc. (AMEX:DGSE), Coach, Inc. (NYSE:COH), Signet Jewelers (NYSE:SIG), Amazon.com (NASDAQ:AMZN), eBay (NASDAQ:EBAY), Nordstrom (NYSE:JWN) and Macy’s (NYSE:M).
  • Cubist Pharma (NASDAQ:CBST): Needham reiterated its rating of Buy for this stock.  It changed its price target from $33 to $39.  About the company:  Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company’s lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections.
  • Marvell (NASDAQ:MRVL): Needham reiterated its rating of Buy for this stock.  It changed its price target from $22.5 to $19.5.  About the company: Marvell Technology Group Ltd. designs, develops, and markets integrated circuits for communications-related markets. The Company’s products provide the interface between analog signals and the digital information used in computing and communications systems. Marvell’s technology is applied to the broadband data communications market. Competitors to Watch: Texas Instruments Inc. (NYSE:TXN), Intel Corporation (NASDAQ:INTC), Broadcom Corporation (NASDAQ:BRCM), PLX Technology, Inc. (NASDAQ:PLXT), Standard Microsystems Corp. (NASDAQ:SMSC), PMC-Sierra, Inc. (NASDAQ:PMCS), LSI Corporation (NYSE:LSI), STMicroelectronics N.V. (NYSE:STM), and NVIDIA Corporation (NASDAQ:NVDA).
  • Broadcom (NASDAQ:BRCM): Needham reiterated its rating of Buy for this stock.  It changed its price target from $44 to $40.  About the company: Broadcom Corporation provides integrated silicon solutions that enable broadband digital data transmission of voice, data, and video content to the home and within the business enterprise. The Company designs, develops, and supplies integrated circuits for cable set-top boxes, cable modems, high-speed networking, direct satellite and digital broadcast, and digital subscriber line. Competitors to Watch: QUALCOMM, Inc. (NASDAQ:QCOM), Texas Instruments Inc. (NYSE:TXN), Intel Corporation (NASDAQ:INTC), Analog Devices, Inc. (NYSE:ADI), NVIDIA Corporation (NASDAQ:NVDA), Marvell Tech. Group Ltd. (NASDAQ:MRVL), PMC-Sierra, Inc. (NASDAQ:PMCS), Infineon Tech. AG (ADR) (IFNNY), TranSwitch Corporation (NASDAQ:TXCC), and Zoran Corporation (NASDAQ:ZRAN).
  • Google (NASDAQ:GOOG): Collins Stewart reiterated its rating of Buy for this stock.  It changed its price target from $680 to $725.  About the company: Google Inc. is a global technology company that provides a web based search engine through its website. The Company offers a wide range of search options, including web, image, groups, directory, and news searches.
  • MaxLinear (NYSE:MXL): Needham reiterated its rating of Buy for this stock.  It changed its price target from $13 to $11.  About the company: MaxLinear, Inc. provides integrated, radio-frequency analog and mixed-signal semiconductor solutions for broadband communications applications. The Company’s products enable the display of broadband video in a wide range of electronic devices, including cable and terrestrial set top boxes, digital televisions, mobile handsets, personal computers, and netbooks.
  • Marriott (NYSE:MAR): Rodman & Renshaw reiterated its rating of Mkt Perform for this stock.  It changed its price target from $43 to $38.  About the company: Marriott International Inc. is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands. Competitors to Watch:Starwood Hotels & Resorts Worldwide, Inc (NYSE:HOT), Wyndham Worldwide Corporation (NYSE:WYN), Hyatt Hotels Corporation (NYSE:H), Intercontinental Hotels Group plc (NYSE:IHG), and Silverleaf Resorts, Inc. (NASDAQ:SVLF).
  • Idera Pharma (NASDAQ:IDRA):  Rodman & Renshaw reiterated its rating of Mkt Outperform for this stock.  It changed its price target from $6 to $4.  About the company: Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

(Note: Data on stock ratings is sourced from here.  All data are assumed to be accurate.)

Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!

More from The Cheat Sheet